Abstract:Back in the year 2009, we presented in this journal a neonate with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla 1 . After prenatal ultrasound examination at 21 weeks had revealed intrauterine growth retardation and pericardial effusions, labor was induced at 38 weeks of pregnancy. The patient was hypotonic at birth, had respiratory insufficiency necessitating intubation and artificial ventilation, hepatomegaly and severe cardiomegaly. Intensive care was withdrawn in accordance with parents' wishes on day 38. At the time, the patient's causal genetic defect had remained unknown, yet clinical and biochemical evidence ticked all the boxes of an underlying mitochondrial defect. Postmortem spectrophotometric evaluation then revealed decreased oxidative phosphorylation activities in heart muscle (complex IV) and liver (complexes I, III, IV and V), and normal activities in skeletal muscle and cultured skin fibroblasts. Blue-native polyacrylamide gel electrophoresis of liver extracts confirmed decreased activities of complexes III and IV and showed the presence of subcomplexes of complex V. Thanks to the great genetic leap forward taken by medical research ever since, we were now able to thoroughly investigate the patient's whole exome extracted from preserved cultured skin fibroblasts. These investigations picked up compound heterozygous missense variants in the gene encoding the mitochondrial leucyl-tRNA synthetase ( LARS2 ): c.302 A > G (p.His101Arg) and c.516 G > T (p.Arg172Ser). Nuclear-encoded mitochondrion-specific aminoacyl-tRNA synthetases exist for 17 of the 20 proteogenic amino acids, and pathogenic mutations have now been reported for each one of these 2 . At the time we published our casus, LARS2 defects had not been reported, yet between the year 2013 and now, a total of 23 patients have been described that carry disease-causing LARS2 variants (Table 1) 1,3,4,5,6,7,8,9,10,11,12,13 . Their diverse associated disease phenotypes, which include Perrault syndrome, multisystem disease, leukodystrophy and intellectual disability, do not appear to have an obvious link with genotype. With the casus we presented in this journal and now have characterized at the molecular level, more than twenty patients with 18 unique combinations of disease-causing LARS2 variants have been reported so far, only one was homozygous the others concerned compound heterozygous variants. Table 1 Published patients carrying disease-causing LARS2 variants. Full size table

A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia

Novel RARS2 Variants: Updating the Diagnosis and Pathogenesis of Pontocerebellar Hypoplasia Type 6.

Abstract 18698: PCBP1 Regulates Alternative Splicing of Aars2 in Congenital Cardiomyopathy

Distinct Magnetic Resonance Imaging Features in a Patient with Novel RARS2 Mutations: A Case Report and Review of the Literature.

A Term Neonate with Early Myoclonic Encephalopathy Caused by RARS2 Gene Variants: a Case Report.

Study of Novel NARS2 Variants in Patient of Combined Oxidative Phosphorylation Deficiency 24

Instability of the mitochondrial alanyl-tRNA synthetase underlies fatal infantile-onset cardiomyopathy

Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report

A Novel Compound Heterozygous Mutation in AARS2 Gene (c.965 G > A, P.r322h; C.334 G > C, P.g112r) Identified in a Chinese Patient with Leukodystrophy Involved in Brain and Spinal Cord

The Genotypic and Phenotypic Spectrum of PARS2-related Infantile-Onset Encephalopathy.

An Adolescence-Onset Male Leukoencephalopathy with Remarkable Cerebellar Atrophy and Novel Compound Heterozygous AARS2 Gene Mutations: a Case Report

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy

A novel variant in disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure

Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview

Neonatal lactic acidosis explained by LARS2 defect

Hearing impairment-associated KARS mutations lead to defects in aminoacylation of both cytoplasmic and mitochondrial tRNA Lys

Recurrent acute liver failure in alanyl-tRNA synthetase-1 (AARS1) deficiency

A second RUBCN variant associated with epileptic encephalopathy and neurodevelopmental delay

TARS2 c.470 C > G is a chinese-specific founder mutation in three unrelated families with mitochondrial encephalomyopathy

Bi‐allelic mutations in HARS1 severely impair histidyl‐tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome